SAGE THERAPEUTICS INC's ticker is and the CUSIP is 78667J908. A total of 5 filers reported holding SAGE THERAPEUTICS INC in Q1 2021. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $715,110 | +1.3% | 33,000 | -3.8% | 0.00% | -100.0% |
| Q3 2023 | $705,894 | -46.3% | 34,300 | +125.7% | 0.00% | -50.0% |
| Q4 2020 | $1,315,000 | -9.6% | 15,200 | -36.1% | 0.00% | 0.0% |
| Q3 2020 | $1,455,000 | -10.4% | 23,800 | +5.8% | 0.00% | -50.0% |
| Q4 2019 | $1,624,000 | +126.2% | 22,500 | +200.0% | 0.00% | +100.0% |
| Q4 2018 | $718,000 | – | 7,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SPHERA FUNDS MANAGEMENT LTD. | 1,000 | $3,013,000 | 0.78% |
| SABBY MANAGEMENT, LLC | 4,009 | $12,079,000 | 0.63% |
| Iguana Healthcare Management, LLC | 50,000 | $1,507,000 | 0.61% |
| SIMPLEX TRADING, LLC | 38 | $8,000 | 0.00% |
| GROUP ONE TRADING, L.P. | 100 | $3,000 | 0.00% |
| Citadel Advisors | 11,500 | $346,000 | 0.00% |